Researchers tested the blood samples for "molecular signals of advanced colorectal cellular changes" and then compared those results with the colonoscopy findings. The sensitivity of the test ...

The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...

Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says.

The researchers tried the experimental blood test on more than 40,000 people aged between 45 to 85 at 200 sites across the ...

A new study has found that taking a small daily dose of aspirin could help stop colon cancer from returning in some patients.

Refining colorectal cancer screening strategies using polygenic risk scores and classical risk factors: A proof-of-concept study in the UK Biobank cohort. Multivariable logistic regression model of ...

While colon cancer has traditionally been associated with older adults, recent data reveals an alarming trend: cases are ...

A blood-based test (Freenome) may provide a new option for colorectal cancer (CRC) screening in the average-risk U.S.

An investigational blood test can detect colorectal cancer (CRC) in patients at average risk of CRC, a study suggests.

St. Luke's Hospital is using artificial intelligence (AI) technology that can help doctors find early signs of Colon Cancer.